Robert Glenn Hubbard - 14 Jun 2022 Form 4 Insider Report for METLIFE INC (MET)

Role
Director
Signature
/s/ Anna Nazarenko, Authorized Signer
Issuer symbol
MET
Transactions as of
14 Jun 2022
Transactions value $
$35,260
Form type
4
Date filed
16 Jun 2022, 16:28
Previous filing
19 Apr 2023
Next filing
23 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award $35.3K +570 +0.73% $61.86 78.9K 14 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred.